Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.00
- Piotroski Score 5.00
- Grade Overweight
- Symbol (EHC)
- Company Encompass Health Corporation
- Price $99.42
- Changes Percentage (0.5%)
- Change $0.49
- Day Low $98.09
- Day High $99.65
- Year High $104.55
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
- Last Earnings 10/17/2024
- Ex-Dividend for 5/16 Dividend 01/02/2025
- Dividend Payable 01/15/2025
- Today N/A
- Next Earnings (Estimated) 02/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $100.00
- High Stock Price Target $110.00
- Low Stock Price Target $83.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.82
- Trailing P/E Ratio 22.21
- Forward P/E Ratio 22.21
- P/E Growth 22.21
- Net Income $352.00 M
Income Statement
Quarterly
Annual
Latest News of EHC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
Utilizing Zacks Style Scores can aid investors in selecting stocks based on value, growth, and momentum. GE HealthCare Technologies Inc., a top medical technology provider, holds a Zacks Rank #3 with ...
By Yahoo! Finance | 2 weeks ago -
GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements
AI's influence extends beyond investing, with companies like Penguin Random House and The New York Times facing copyright issues related to AI use. Anthropic prioritizes AI safety, contrasting with Op...
By Yahoo! Finance | 4 weeks ago -
Jim Cramer on GE HealthCare Technologies (NASDAQ:GEHC) Stock: Will Bounce Back
Jim Cramer's latest portfolio update features GE HealthCare Technologies Inc as the 10th top stock, despite its recent underperformance. Cramer is optimistic about the rebound of tech stocks and the p...
By Yahoo! Finance | 1 month ago
